
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
TIM CRISPR/Cas9 KO Plasmid (m) | sc-423480 | 20 µg | $397.00 |
Mouse Tpi1 encodes triosephosphate isomerase (TIM), a core glycolytic enzyme that catalyzes the reversible interconversion of dihydroxyacetone phosphate and glyceraldehyde-3-phosphate. By maintaining efficient flux through glycolysis, TIM supports cellular ATP production, redox balance, and metabolic coupling to pathways such as the pentose phosphate pathway and anaplerotic inputs into the TCA cycle. Tpi1 activity is therefore integral to bioenergetic homeostasis in proliferative and differentiated tissues, and its dysregulation is relevant to studies of metabolic stress responses, hypoxia adaptation, and glycolysis-dependent phenotypes. Altered glycolytic control involving Tpi1 is also commonly examined in models of neurological dysfunction, hemolytic pathology, and cancer-associated metabolic reprogramming.
TIM CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Tpi1 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Tpi1 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Tpi1 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish TIM protein expression.
This CRISPR knockout system enables efficient generation of Tpi1-deficient cell models for investigation of TIM signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.